Afuco™ Anti-CSF2 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-259) (CAT#: AFC-TAB-259)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CSF2. It is an immunomodulator. It binds to reticulon 4.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Isotype Switching:
  • Fc Engineering:
  • Modalities:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location
RNA Expression

Specifications

  • Immunogen
  • Recombinant full length protein (Mouse) expressed in yeast.
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Applications
  • IP, IF, FuncS, FC, Neut, ELISA
  • Conjugate
  • Unconjugated
  • Generic Name
  • Namilumab
  • Related Disease
  • Rheumatoid arthritis (RA)

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • CSF2; colony stimulating factor 2 (granulocyte-macrophage); granulocyte-macrophage colony-stimulating factor; GM CSF; GMCSF; granulocyte macrophage colony stimulating factor; CSF

Related Resources

  • Biosimilar Overview
  • Related Signaling Pathways
Please refer to Namilumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Namilumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Namilumab"

DrugMonitor™ Anti-Namilumab Antibody (VS-1224-YC786)
Namilumab has been trialed for plaque psoriasis and rheumatoid arthritis treatment. The DrugMonitor™ Anti-Namilumab Antibody (VS-1224-YC786) is an anti-drug antibody (ADA) against Namilumab. This drug-based antibody is raised in mice immunized with the Namilumab. The anti-Namilumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Namilumab in samples.

See other products for "CSF2"

Select a product category from the dropdown menu below to view related products.
Please select product type
IgG Antibody Products Fab Antibody Products Mouse Antibody Products Chimeric Antibody Products Humanized Antibody Products Human Antibody Products Neutralizing Antibody Products Blocking Antibody Products Rabbit Monoclonal Antibody Products ScFv Antibody Products ADCC Enhanced Antibody Products Antibody Magnetic Beads

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-259. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare